BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,320 | -25.2% | 326,435 | -9.7% | 0.28% | -18.1% |
| Q2 2023 | $16,479 | +3.6% | 361,700 | -7.8% | 0.34% | +1.2% |
| Q1 2023 | $15,908 | -13.2% | 392,200 | +9.1% | 0.34% | -17.1% |
| Q4 2022 | $18,329 | -99.0% | 359,600 | +920.4% | 0.41% | +789.1% |
| Q3 2022 | $1,898,000 | +62.1% | 35,240 | +153.7% | 0.05% | +142.1% |
| Q1 2021 | $1,171,000 | +5.0% | 13,890 | 0.0% | 0.02% | -9.5% |
| Q4 2020 | $1,115,000 | -0.2% | 13,890 | 0.0% | 0.02% | -16.0% |
| Q3 2020 | $1,117,000 | -6.6% | 13,890 | 0.0% | 0.02% | -10.7% |
| Q2 2020 | $1,196,000 | +13.6% | 13,890 | +7.1% | 0.03% | -3.4% |
| Q1 2020 | $1,053,000 | +5.0% | 12,970 | +8.1% | 0.03% | +38.1% |
| Q4 2019 | $1,003,000 | +279.9% | 12,000 | +135.3% | 0.02% | +320.0% |
| Q1 2017 | $264,000 | +16.8% | 5,100 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $226,000 | -86.8% | 5,100 | -85.8% | 0.01% | -85.7% |
| Q3 2016 | $1,709,000 | -13.9% | 35,900 | -18.2% | 0.04% | -20.5% |
| Q2 2016 | $1,985,000 | +10.1% | 43,900 | 0.0% | 0.04% | +12.8% |
| Q1 2016 | $1,803,000 | -73.0% | 43,900 | -74.9% | 0.04% | -73.3% |
| Q4 2015 | $6,680,000 | +16.1% | 175,109 | 0.0% | 0.15% | +10.6% |
| Q3 2015 | $5,752,000 | -80.3% | 175,109 | -58.1% | 0.13% | -77.5% |
| Q2 2015 | $29,219,000 | +28.2% | 417,829 | +25.6% | 0.59% | +34.6% |
| Q1 2015 | $22,787,000 | +17.0% | 332,650 | +25.2% | 0.44% | +14.1% |
| Q4 2014 | $19,477,000 | +7.2% | 265,750 | +5.0% | 0.38% | +3.8% |
| Q3 2014 | $18,164,000 | – | 253,090 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |